Glucocorticoid therapy and risk of bladder cancer (Q37401519)

20 August 2017

Glucocorticoid therapy and risk of bladder cancer (English)

1 reference

20 August 2017

1 reference

5

1 reference

20 August 2017

K Dietrich

1

1 reference

20 August 2017

A Schned

2

1 reference

20 August 2017

J Fortuny

3

1 reference

20 August 2017

J Heaney

4

1 reference

20 August 2017

K T Kelsey

6

1 reference

20 August 2017

M R Karagas

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

22 September 2009

1 reference

British Journal of Cancer

20 August 2017

1 reference

20 August 2017

101

1 reference

20 August 2017

8

1 reference

20 August 2017

1316-1320

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605314

20 August 2017

0 references

cites work

Selenium and risk of bladder cancer: a population-based case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Polyoma virus infection and urothelial carcinoma of the bladder following renal transplantation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Bladder carcinoma among live-donor renal transplant recipients: a single-centre experience and a review of the literature

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cancer incidence before and after kidney transplantation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Treatment and outcome of invasive bladder cancer in patients after renal transplantation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cancer risk following organ transplantation: a nationwide cohort study in Sweden

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Non-melanoma skin cancers and glucocorticoid therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

TP53 alterations and patterns of carcinogen exposure in a U.S. population-based study of bladder cancer.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cancer incidence in a kidney-transplanted population.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cancer risk in patients on dialysis and after renal transplantation

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Statistical methods in cancer research. Volume I - The analysis of case-control studies.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2768444

Cancer risk after renal transplantation in the nordic countries, 1964-1986

2 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605314

Survival Following the Diagnosis of Noninvasive Bladder Cancer: WHO/International Society of Urological Pathology Versus WHO Classification Systems

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605314

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

21 January 2018

1 reference

12 December 2020

Epidemiology and etiology of bladder cancer

1 reference

12 December 2020

Bladder cancer in renal transplant recipients

1 reference

12 December 2020

Cancer incidence in a kidney-transplanted population

1 reference

12 December 2020

A different look at corticosteroids

1 reference

12 December 2020

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

1 reference

12 December 2020

Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma

1 reference

12 December 2020

Sex and racial differences in bladder cancer presentation and mortality in the US

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605314

1 reference

20 August 2017

1 reference

20 August 2017

1 reference